Elucidating the precise pharmacological mechanism of action (MOA) of naturally occurring compounds might be tough. While Tarselli et al. (60) developed the main de novo artificial pathway to conolidine and showcased this naturally developing compound correctly suppresses responses to the two chemically induced and inflammation-derived pain, the pharmacologic target https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers